Parkinson’s Disease Epidemiology Analysis and Forecast to 2033
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
Parkinson’s Disease Report Overview
In the 7MM, there were 2,636,930 diagnosed prevalent cases of Parkinson’s Disease in 2023. The market will register an AGR of more than 1% during 2023-2033. This increase in the cases of PD across the 7MM is primarily attributed to changes in the underlying population demographics. Parkinson’s disease (PD) is an incurable neurodegenerative disease clinically categorized as a movement disorder with prominent motor symptoms, including tremors, rigidity, and bradykinesia. The clinical presentation of PD is characterized by postural instability, resting tremors, and gait problems that result from the progressive loss of A9 dopaminergic neurons in the substantia nigra pars compacta.
Parkinson’s Disease Market Outlook, 2023-2033 (Diagnosed Prevalent Cases)
Buy the Full Report for More Insights into the Parkinson’s Disease Market Forecast
The Parkinson’s Disease market research report provides an overview of the risk factors, comorbidities, and global and historical trends for PD in the seven major markets (7MM: the US, France, Germany, Italy, Spain, the UK, and Japan). The report features a 10-year epidemiological forecast for the diagnosed prevalent cases of PD segmented by sex and age (beginning at age 18 years and ending at ages 85 years and older).
| Market Size (2022) | 2,636,930 Cases |
| AGR (2023-2033) | >1% |
| Forecast Period | 2023-2033 |
| Key Countries | · The US
· France · Germany · Spain · Italy · The UK · Japan |
| Key Sex Segments | · Men
· Women |
| Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Parkinson’s Disease Market Segmentation by Country
The key countries across the 7MM are the US, France, Germany, Spain, Italy, the UK, and Japan. In 2023, the US accounted for the highest percentage of diagnosed prevalent cases of Parkinson’s Disease in the 7MM. Furthermore, the country will experience the largest growth by 2033.
`Parkinson’s Disease Market Analysis by Country, 2023 (%)
Buy the Full Report for More Country Insights into the Parkinson’s Disease Market
Download a Free Report Sample
Parkinson’s Disease Market Segmentation by Sex
Based on sex, the market can be segmented into men and women. In 2023, the diagnosed prevalent cases of Parkinson’s Disease in the 7MM were higher in men than women. Among the 7MM, Japan had the largest difference in the diagnosed prevalent cases of Parkinson’s Disease between men and women.
Parkinson’s Disease Market Analysis by Sex, 2023 (%)
Buy the Full Report for More Sex Insights into the Parkinson’s Disease Market
Segments Covered in the Report
Parkinson’s Disease Market Country Outlook (Diagnosed Prevalent Cases)
- The US
- France
- Germany
- Spain
- Italy
- The UK
- Japan
Parkinson’s Disease Market Sex Outlook (Diagnosed Prevalent Cases)
- Men
- Women
Scope
- This report provides an overview of the risk factors, comorbidities, and global and historical trends for PD in the seven major markets (7MM: the US, France, Germany, Italy, Spain, the UK, and Japan).
- The report features a 10-year epidemiological forecast for the diagnosed prevalent cases of PD segmented by sex and age (beginning at age 18 years and ending at ages 85 years and older). The diagnosed prevalent cases are further categorized by Hoehn and Yahr (HY) clinical staging (stages I, II, III, IV, and V) and grouped into early (equivalent to HY clinical stages I–II), moderate-advanced (equivalent to HY clinical stages III–V), and advanced (equivalent to HY clinical stages IV–V).
- Additionally, the report covers diagnosed prevalent cases based on the inheritance type, including sporadic (idiopathic) and familial forms of PD. It also includes segments on motor complications, such as motor fluctuations and levodopa-induced dyskinesia, as well as neuropsychiatric complications, classified into psychosis, dementia, and hallucinations.
- To forecast the diagnosed prevalent cases of PD in the 7MM, GlobalData epidemiologists selected nationally representative, population-based studies that provided these epidemiological data. In addition, the forecast is supported by robust, country-specific data obtained from various authentic sources, such as research articles published in peer-reviewed journals.
Reasons to Buy
- The Parkinson’s disease (PD) epidemiology series will allow you to:
- Develop business strategies by understanding the trends shaping and driving the global PD market.
- Quantify patient populations in the global PD market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups that present the best opportunities for PD therapeutics in each of the markets covered.
Table of Contents
Table
Figures
Frequently asked questions
-
How many diagnosed prevalent cases of Parkinson’s Disease were seen in the 7MM in 2023?
In 2023, there were 2,636,930 diagnosed prevalent cases of Parkinson’s Disease in the 7MM.
-
What will the growth rate of the Parkinson’s Disease market be during the forecast period?
The diagnosed prevalent cases of Parkinson’s Disease will register an AGR of more than 1% during 2023-2033.
-
Which was the leading sex segment in the Parkinson’s Disease market in 2023?
In 2023, the number of diagnosed prevalent cases of Parkinson’s Disease was higher in men in the 7MM combined.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Related reports
View more Parkinson's Disease reports


